Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Infections and infestations – page 9

  • 686 clinical trials
  • 263 recruiting
  • 279 conditions
  • 27 countries

Conditions in this area

279 conditions with trials, the busiest first

HIV infection78COVID-1939Pneumonia32Influenza29Sepsis29Respiratory syncytial virus infection20Post-acute COVID-19 syndrome19Urinary tract infection19Septic shock17Chronic hepatitis B16Bacterial infection14Hepatitis D14Cytomegalovirus infection13Appendicitis10Hepatitis B10Pneumonia bacterial10Fungal infection9Irritable bowel syndrome8Medical device site joint infection8Pyelonephritis acute7Staphylococcal bacteraemia7Staphylococcal infection7T-cell type acute leukaemia7Lower respiratory tract infection6+255

Clinical trials in Infections and infestations

686 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

686 clinical trials

Toxic epidermal necrolysis

Recruiting

Treatment with Mesenchymal Stromal Cells for Adults with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS-TEN) Affecting More Than 10% of Body Surface

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Allogeneic Adipose-Derived Mesenchymal Stromal Cells, Ex-Vivo Expanded
  • Sponsor:Assistance Publique Hopitaux De Paris

Rabies+1

Recruiting

Study on Pain and Usability of Rabies Vaccine Injection Techniques in Children Aged 4-14 Using Inactivated Rabies Virus (Strain Flury LEP)

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · Healthy volunteers
  • Substances:Rabies virus (inactivated) strain Flury LEP
  • Sponsor:Institute Of Tropical Medicine

Rabies+1

Recruiting

Study of Single-Dose Rabies Vaccine (Inactivated Flury LEP Strain) Immunity After Five Years: Testing Booster Response in Previously Vaccinated Adults

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Rabies virus (inactivated) strain Flury LEP
  • Sponsor:Leiden University Medical Center

Laryngitis

Recruiting

Study on the Effectiveness of Prednisolone for Treating Acute Laryngitis in Vocal Professionals

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · Healthy volunteers
  • Substances:Prednisolone
  • Sponsor:HUS-Yhtymae

Respiratory syncytial virus infection

Recruiting

Study on the Safety and Immune Response of rBCG-N-RSV Vaccine Compared to BCG Vaccine in Adults Over 60 with Respiratory Syncytial Virus (RSV) Concerns

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Sponsor:Biothervax SpA

Influenza

Recruiting

Study on the Effectiveness of High-Dose vs. Standard-Dose Quadrivalent Influenza Vaccine in Preventing Flu in Adults Aged 65-79 in Galicia, Spain

Registered drugNo placebo
Countries:SpainSpain
  • Participants:65+ years · Healthy volunteers
  • Substances:A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224)
  • Sponsor:Complexo Hospitalario Universitario De Santiago

Monkeypox+1

Recruiting

Study of Different Doses of MVA-BN Vaccine Booster for Adults with Mpox: Comparing Standard and Reduced Doses

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Modified Vaccinia Ankara – Bavarian Nordic Live Virus
  • Sponsor:Leiden University Medical Center

Dengue fever

Recruiting

Study on the Effects of the Dengue Vaccine Qdenga on Antibody Levels in Swedish Travelers

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:DENGUE VIRUS, SEROTYPE 2, EXPRESSING DENGUE VIRUS, SEROTYPE 4, SURFACE PROTEINS, LIVE, ATTENUATED
  • Sponsor:Region Vaesterbotten

Measles

Recruiting

Study on Immunity to Measles and Chickenpox in Children with Cancer Using Measles, Mumps, Rubella, and Varicella Vaccines

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · Healthy volunteers
  • Substances:Measles virus edmonston-schwarz strain (live, attenuated) produced in chick embryo cells
  • Sponsor:Vaestra Goetalandsregionen

COVID-19

Recruiting

Study comparing intranasal COVID-19 vaccine (LVT-001) with mRNA vaccine (bretovameran) as booster doses in healthy adults

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · Healthy volunteers
  • Substances:Bretovameran
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Pathogen resistance

Recruiting

Study of Oral Fecal Microbiota Transplantation in Patients Colonized with Multi-Drug Resistant Bacteria

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Placebo
  • Sponsor:Assistance Publique Hopitaux De Paris

Varicella

Recruiting

Study on the Immune Response and Safety of a New Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000025896
  • Sponsor:GlaxoSmithKline Biologicals

Substances studied in this area

The therapies tested most often in Infections and infestations trials.

Sodium Chloride52 clinical trialsAmoxicillin35 clinical trialsEmtricitabine33 clinical trialsTenofovir Alafenamide33 clinical trialsLinezolid32 clinical trialsClavulanic Acid28 clinical trialsRifampicin25 clinical trialsSulfamethoxazole25 clinical trialsTrimethoprim25 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.